Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 5 minute read Healthcare Industry News The hidden dangers of obesity: What you need to know! Obesity is a complex health issue that has evolved into a global epidemic, affecting millions of individuals across… bypharmanewsdailyMarch 8, 2025